Cases

COLLOTON, Circuit Judge. Laurie Simpson appeals the district court’s dismissal of her qui tam action under the False Claims Act, 31 U.S.C. §§ 3729-3733 (2006), for lack of subject matter jurisdiction.* The court concluded *961it lacked jurisdiction because Simpson’s action was based on public disclosure of allegations or transactions, an

LINARES, Chief District Judge. This matter comes before the Court by way of cross-motions for partial summary judgment by Plaintiff Relator Laurie Simpson, (ECF No. 324), and Defendants Bayer Corporation, Bayer Healthcare *397Pharmaceuticals, Inc., and Bayer Healthcare, LLC (collectively, "Bayer"), (ECF No. 323). Bayer has opposed Relator's m

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.

OPINION ERIC L. FRANK, CHIEF U.S. BANKRUPTCY JUDGE I. INTRODUCTION In this adversary proceeding, Plaintiffs John Larson (“Larson”) and Greg Bayer (“G. Bayer”) (collectively, “the Plaintiffs”) requested a determination that their pre-petition claims against the Debtor, Nich*204olas Bayer (“N. Bayer”), are excepted from discharge

OPINION WILLIAM L. STANDISH, District Judge. This civil action arises out of the denial of federal income tax credits for qualified research expenses claimed by-Plaintiffs, Bayer Corporation and Subsidiaries (“Bayer”), for the years 1990-2006. Before the Court is Bayer’s Amended Motion for a Case Management/Protective Order Based on Statistical Sampling (“Amended Sampling Motion”). (Docket No.

OPINION ERIC L. FRANK, Chief Judge. I. INTRODUCTION The dispute giving rise to this adversary proceeding stems from the sale of the as*495sets of a start-up business, Saxby’s Coffee, Inc. (“SCI”), to owners who subsequently operated the enterprise through a new entity, Saxby’s Coffee Worldwide, LLC (“SCW”). The ill-fated transac

MEMORANDUM OPINION ROSEMARY M. COLLYER, District Judge. Bayer Healthcare, LLC patented a highly-successful drug and method for treating bovine respiratory disease named Baytril® 100. While Baytril can be administered over three days, its real advantage is that it can also be administered in a single injection to cure the animal. In 2006, Bayer submitted a C

C. A. Fed. Cir. Certiorari denied. Justice Alito took no part in the consideration or decision of this petition.

SUMMARY ORDER Plaintiffs-appellants, women who were injured When the intrauterine device (“IUD”) Mirena injured their uteruses (“Plaintiffs”), appeal the July 29, 2016 judgment of the District Court. On appeal, Plaintiffs argue that the District Court .improperly excluded their expert witnesses on general causation in a March 8, 2016 Opinion and Order, and improperly granted summary judgment for defendant-ap-pellee B

LOKEN, Circuit Judge, concurring in part and dissenting in part. I concur in the court’s cogent description of this dispute and its procedural history. I join Part II.B. of its opinion, which affirms the dismissal of relator’s FCA claims relating to federal health insurance reimbursements. In Part H.A., I agree with the conclusions that relator sufficiently pleaded fraud in the

C. A. 8th Cir. Cer-tiorari denied.

C. A. 7th Cir. Certiorari denied.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit granted. Same case below, 593 F.3d 716.

*302 Justice Kagan delivered the opinion of the Court. * In this case, a Federal District Court enjoined a state court from considering a plaintiff’s request to approve a class action. The District Court did so because it had ea

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.

(Slip Opinion) OCTOBER TERM, 2010 1 Syllabus NOTE: Where it is feasible, a syllabus (headnote) will be released, as is being done in connection with this case, at the time the opinion is issued. The syllabus constitutes no part of the opinion of the Court but has been prepared by the Reporter of Decisions for the convenience of the reader. See United States v. Detroit

651 A.2d 308 (1994) Talmadge H.R. BAYER, Appellant, v. UNITED STATES, Appellee. Robert R. BIANCHI, Appellant, v. UNITED STATES, Appellee. Nos. 93-CF-501, 93-CF-532. District of Columbia Court of Appeals. Argued November 16, 1994. Decided December 22, 1994. *309 Gary M. Sidell, for appellant Bayer.

Vacated and remanded by published ■ opinion. Judge AGEE - wrote the. opinion, in which Judge FLOYD and Judge THACKERjoined. AGEE, Circuit Judge: In this unfair competition case, we consider whether the Lanham Act permits the owner of a foreign trademark and its sister company to pursue false association, false advertising, and trademark cancellation clai

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied. Same case below, 645 F.3d 690.

TRANSFER ORDER JOHN G. HEYBURN II, Chairman. Before the entire Panel *: Plaintiff moves, pursuant to Rule 7.4, R.P.J.P.M.L., 199 F.R.D. 425, 435-36 (2001), to vacate our order conditionally transferring the ac*1370tion to the District of Minnesota for inclusion in MDL No. 1431. Defendants Bayer Corp. and Bayer AG oppose the motion.